Literature DB >> 13201846

Studies on the C antibody of group O serum with special reference to its role in hemolytic disease of the newborn.

L J UNGER, A S WIENER.   

Abstract

Entities:  

Keywords:  ANEMIA, HEMOLYTIC/in infant and child; BLOOD GROUPS

Mesh：

Substances：

Year:  1954        PMID： 13201846

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  8 in total

1.  [BLOOD GROUP A-LIKE FORSSMAN ANTIGENS IN MYXOVIRUSES CULTURED IN A CHICKEN EGG: THEIR POSSIBLE PATHOGENETIC SIGNIFICANCE IN VACCINES].

Authors:  G F SPRINGER; R SCHUSTER
Journal:  Klin Wochenschr       Date:  1964-08-15

2.  ABO incompatibility and haemolytic disease of the newborn.

Authors:  G H VALENTINE
Journal:  Arch Dis Child       Date:  1958-06       Impact factor: 3.791

3.  Some studies on the naturally occurring leucocyte agglutinins.

Authors:  J J BUTLER
Journal:  J Clin Invest       Date:  1956-10       Impact factor: 14.808

4.  [Notable increase of anti-B excretion in the saliva of O- compared with A1 carriers].

Authors:  O PROKOP
Journal:  Blut       Date:  1961-07

5.  The specificity of the cross-reacting antibodies in blood group O sera which produce mixed agglutination.

Authors:  D Franks; R Liske
Journal:  Immunology       Date:  1968-03       Impact factor: 7.397

6.  The cross-reacting antibodies of group O sera: immunological studies and possible explanation of the observed facts.

Authors:  B E Dodd; P J Lincoln; K E Boorman
Journal:  Immunology       Date:  1967-01       Impact factor: 7.397

7.  [Varying influence of increased enteral antigen absorption on the behavior of "natural" antibodies in O and A blood group subjects. Comparative blood group serological studies on patients with ulcerative colitis and healthy persons].

Authors:  P Arend; G Fehlhaber
Journal:  Klin Wochenschr       Date:  1969-05-15

8.  Blood group isoantibody stimulation in man by feeding blood group-active bacteria.

Authors:  G F Springer; R E Horton
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.